Crossref journal-article
Springer Science and Business Media LLC
Nature (297)
Bibliography

Lin, S.-C., Lo, Y.-C., & Wu, H. (2010). Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signalling. Nature, 465(7300), 885–890.

Authors 3
  1. Su-Chang Lin (first)
  2. Yu-Chih Lo (additional)
  3. Hao Wu (additional)
References 58 Referenced 925
  1. O’Neill, L. A. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol. Rev. 226, 10–18 (2008) (10.1111/j.1600-065X.2008.00701.x) / Immunol. Rev. by LA O’Neill (2008)
  2. Takeda, K., Kaisho, T. & Akira, S. Toll-like receptors. Annu. Rev. Immunol. 21, 335–376 (2003) (10.1146/annurev.immunol.21.120601.141126) / Annu. Rev. Immunol. by K Takeda (2003)
  3. Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783–801 (2006) (10.1016/j.cell.2006.02.015) / Cell by S Akira (2006)
  4. Beutler, B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430, 257–263 (2004) (10.1038/nature02761) / Nature by B Beutler (2004)
  5. Verstak, B., Hertzog, P. & Mansell, A. Toll-like receptor signalling and the clinical benefits that lie within. Inflamm. Res. 56, 1–10 (2007) (10.1007/s00011-007-6093-7) / Inflamm. Res. by B Verstak (2007)
  6. Marx, J. Biomedicine. Puzzling out the pains in the gut. Science 315, 33–35 (2007) (10.1126/science.315.5808.33) / Science by J Marx (2007)
  7. O’Neill, L. A. Primer: Toll-like receptor signaling pathways–what do rheumatologists need to know? Nat. Clin. Pract. Rheumatol. 4, 319–327 (2008) (10.1038/ncprheum0802) / Nat. Clin. Pract. Rheumatol. by LA O’Neill (2008)
  8. Marta, M., Meier, U. C. & Lobell, A. Regulation of autoimmune encephalomyelitis by toll-like receptors. Autoimmun. Rev. 8, 506–509 (2009) (10.1016/j.autrev.2009.01.006) / Autoimmun. Rev. by M Marta (2009)
  9. Lande, R. et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449, 564–569 (2007) (10.1038/nature06116) / Nature by R Lande (2007)
  10. Pisitkun, P. et al. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312, 1669–1672 (2006) (10.1126/science.1124978) / Science by P Pisitkun (2006)
  11. Horner, A. A. & Raz, E. Do microbes influence the pathogenesis of allergic diseases? Building the case for Toll-like receptor ligands. Curr. Opin. Immunol. 15, 614–619 (2003) (10.1016/j.coi.2003.09.021) / Curr. Opin. Immunol. by AA Horner (2003)
  12. Chen, R. et al. Cancers take their Toll–the function and regulation of Toll-like receptors in cancer cells. Oncogene 27, 225–233 (2008) (10.1038/sj.onc.1210907) / Oncogene by R Chen (2008)
  13. Dasu, M. R., Devaraj, S., Park, S. & Jialal, I. Increased Toll-like receptor activation and TLR ligands in recently diagnosed type 2 diabetes subjects. Diabetes Care 33, 861–868 (2010) (10.2337/dc09-1799) / Diabetes Care by MR Dasu (2010)
  14. Stewart, C. R. et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nature Immunol. 11, 155–161 (2010) (10.1038/ni.1836) / Nature Immunol. by CR Stewart (2010)
  15. den Dekker, W. K., Cheng, C., Pasterkamp, G. & Duckers, H. J. Toll like receptor 4 in atherosclerosis and plaque destabilization. Atherosclerosis 209, 314–320 (2010) (10.1016/j.atherosclerosis.2009.09.075) / Atherosclerosis by WK den Dekker (2010)
  16. Romero-Sandoval, E. A., Horvath, R. J. & DeLeo, J. A. Neuroimmune interactions and pain: focus on glial-modulating targets. Curr. Opin. Investig. Drugs 9, 726–734 (2008) / Curr. Opin. Investig. Drugs by EA Romero-Sandoval (2008)
  17. O’Neill, L. A. & Bowie, A. G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nature Rev. Immunol. 7, 353–364 (2007) (10.1038/nri2079) / Nature Rev. Immunol. by LA O’Neill (2007)
  18. Dinarello, C. A. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int. Rev. Immunol. 16, 457–499 (1998) (10.3109/08830189809043005) / Int. Rev. Immunol. by CA Dinarello (1998)
  19. Kawai, T. et al. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115–122 (1999) (10.1016/S1074-7613(00)80086-2) / Immunity by T Kawai (1999)
  20. Dunne, A. & O’Neill, L. A. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE 2003, re3 (2003) (10.1126/stke.2003.171.re3) / Sci. STKE by A Dunne (2003)
  21. Bowie, A. & O’Neill, L. A. The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J. Leukoc. Biol. 67, 508–514 (2000) (10.1002/jlb.67.4.508) / J. Leukoc. Biol. by A Bowie (2000)
  22. Beutler, B. et al. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 24, 353–389 (2006) (10.1146/annurev.immunol.24.021605.090552) / Annu. Rev. Immunol. by B Beutler (2006)
  23. Kobayashi, K. et al. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110, 191–202 (2002) (10.1016/S0092-8674(02)00827-9) / Cell by K Kobayashi (2002)
  24. Suzuki, N. et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416, 750–756 (2002) (10.1038/nature736) / Nature by N Suzuki (2002)
  25. Kawagoe, T. et al. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nature Immunol. 9, 684–691 (2008) (10.1038/ni.1606) / Nature Immunol. by T Kawagoe (2008)
  26. Wan, Y. et al. Interleukin-1 receptor-associated kinase 2 is critical for lipopolysaccharide-mediated post-transcriptional control. J. Biol. Chem. 284, 10367–10375 (2009) (10.1074/jbc.M807822200) / J. Biol. Chem. by Y Wan (2009)
  27. Picard, C. et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299, 2076–2079 (2003) (10.1126/science.1081902) / Science by C Picard (2003)
  28. von Bernuth, H. et al. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321, 691–696 (2008) (10.1126/science.1158298) / Science by H von Bernuth (2008)
  29. Lasker, M. V., Gajjar, M. M. & Nair, S. K. Cutting edge: Molecular structure of the IL-1R-associated kinase-4 death domain and its implications for TLR signaling. J. Immunol. 175, 4175–4179 (2005) (10.4049/jimmunol.175.7.4175) / J. Immunol. by MV Lasker (2005)
  30. Motshwene, P. G. et al. An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4. J. Biol. Chem. 284, 25404–25411 (2009) (10.1074/jbc.M109.022392) / J. Biol. Chem. by PG Motshwene (2009)
  31. Park, H. H. et al. The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu. Rev. Immunol. 25, 561–586 (2007) (10.1146/annurev.immunol.25.022106.141656) / Annu. Rev. Immunol. by HH Park (2007)
  32. Burns, K. et al. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197, 263–268 (2003) (10.1084/jem.20021790) / J. Exp. Med. by K Burns (2003)
  33. Janssens, S. et al. MyD88S, a splice variant of MyD88, differentially modulates NF-κB- and AP-1-dependent gene expression. FEBS Lett. 548, 103–107 (2003) (10.1016/S0014-5793(03)00747-6) / FEBS Lett. by S Janssens (2003)
  34. Loiarro, M. et al. Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases. J. Biol. Chem. 284, 28093–28103 (2009) (10.1074/jbc.M109.004465) / J. Biol. Chem. by M Loiarro (2009)
  35. Lawrence, M. C. & Colman, P. M. Shape complementarity at protein/protein interfaces. J. Mol. Biol. 234, 946–950 (1993) (10.1006/jmbi.1993.1648) / J. Mol. Biol. by MC Lawrence (1993)
  36. Li, S., Strelow, A., Fontana, E. J. & Wesche, H. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc. Natl Acad. Sci. USA 99, 5567–5572 (2002) (10.1073/pnas.082100399) / Proc. Natl Acad. Sci. USA by S Li (2002)
  37. Szabo, G., Dolganiuc, A., Dai, Q. & Pruett, S. B. TLR4, ethanol, and lipid rafts: a new mechanism of ethanol action with implications for other receptor-mediated effects. J. Immunol. 178, 1243–1249 (2007) (10.4049/jimmunol.178.3.1243) / J. Immunol. by G Szabo (2007)
  38. Rao, N., Nguyen, S., Ngo, K. & Fung-Leung, W. P. A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling. Mol. Cell. Biol. 25, 6521–6532 (2005) (10.1128/MCB.25.15.6521-6532.2005) / Mol. Cell. Biol. by N Rao (2005)
  39. Hardy, M. P. & O’Neill, L. A. The murine Irak2 gene encodes four alternatively spliced isoforms, two of which are inhibitory. J. Biol. Chem. 279, 27699–27708 (2004) (10.1074/jbc.M403068200) / J. Biol. Chem. by MP Hardy (2004)
  40. Conze, D. B. et al. Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-κB activation. Mol. Cell. Biol. 28, 3538–3547 (2008) (10.1128/MCB.02098-07) / Mol. Cell. Biol. by DB Conze (2008)
  41. Cao, Z. et al. TRAF6 is a signal transducer for interleukin-1. Nature 383, 443–446 (1996) (10.1038/383443a0) / Nature by Z Cao (1996)
  42. Belvin, M. P. & Anderson, K. V. A conserved signaling pathway: the Drosophila Toll-Dorsal pathway. Annu. Rev. Cell Dev. Biol. 12, 393–416 (1996) (10.1146/annurev.cellbio.12.1.393) / Annu. Rev. Cell Dev. Biol. by MP Belvin (1996)
  43. Sun, H., Bristow, B. N., Qu, G. & Wasserman, S. A. A heterotrimeric death domain complex in Toll signaling. Proc. Natl Acad. Sci. USA 99, 12871–12876 (2002) (10.1073/pnas.202396399) / Proc. Natl Acad. Sci. USA by H Sun (2002)
  44. Towb, P., Huaiyu, S. & Wasserman, S. A. Tube is an IRAK-4 homolog in a Toll pathway adapted for development and immunity. J. Innate Immun. 1, 309–321 (2009) (10.1159/000200773) / J. Innate Immun. by P Towb (2009)
  45. Holm, L. & Sander, C. Dali: a network tool for protein structure comparison. Trends Biochem. Sci. 20, 478–480 (1995) (10.1016/S0968-0004(00)89105-7) / Trends Biochem. Sci. by L Holm (1995)
  46. Moncrieffe, M. C., Grossmann, J. G. & Gay, N. J. Assembly of oligomeric death domain complexes during Toll receptor signaling. J. Biol. Chem. 283, 33447–33454 (2008) (10.1074/jbc.M805427200) / J. Biol. Chem. by MC Moncrieffe (2008)
  47. Xiao, T., Towb, P., Wasserman, S. A. & Sprang, S. R. Three-dimensional structure of a complex between the death domains of Pelle and Tube. Cell 99, 545–555 (1999) (10.1016/S0092-8674(00)81542-1) / Cell by T Xiao (1999)
  48. Sun, H. et al. Regulated assembly of the Toll signaling complex drives Drosophila dorsoventral patterning. EMBO J. 23, 100–110 (2004) (10.1038/sj.emboj.7600033) / EMBO J. by H Sun (2004)
  49. Park, H. H. et al. Death domain assembly mechanism revealed by crystal structure of the oligomeric PIDDosome core complex. Cell 128, 533–546 (2007) (10.1016/j.cell.2007.01.019) / Cell by HH Park (2007)
  50. Egelman, E. H. Single-particle reconstruction from EM images of helical filaments. Curr. Opin. Struct. Biol. 17, 556–561 (2007) (10.1016/j.sbi.2007.07.006) / Curr. Opin. Struct. Biol. by EH Egelman (2007)
  51. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997) (10.1016/S0076-6879(97)76066-X) / Methods Enzymol. by Z Otwinowski (1997)
  52. Terwilliger, T. SOLVE and RESOLVE: automated structure solution, density modification and model building. J. Synchrotron Radiat. 11, 49–52 (2004) (10.1107/S0909049503023938) / J. Synchrotron Radiat. by T Terwilliger (2004)
  53. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126–2132 (2004) (10.1107/S0907444904019158) / Acta Crystallogr. D by P Emsley (2004)
  54. Brunger, A. T. et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905–921 (1998) (10.1107/S0907444998003254) / Acta Crystallogr. D by AT Brunger (1998)
  55. Adams, P. D. et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D 58, 1948–1954 (2002) (10.1107/S0907444902016657) / Acta Crystallogr. D by PD Adams (2002)
  56. Collaborative Computational Project. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760–763 (1994) (10.1107/S0907444994003112)
  57. Reynolds, C., Damerell, D. & Jones, S. ProtorP: a protein–protein interaction analysis server. Bioinformatics 25, 413–414 (2009) (10.1093/bioinformatics/btn584) / Bioinformatics by C Reynolds (2009)
  58. Delano, W. L. The PyMol Molecular Graphics System 〈 http://www.pymol.org/ 〉 (2002)
Dates
Type When
Created 15 years, 3 months ago (May 19, 2010, 5:40 a.m.)
Deposited 2 years, 3 months ago (June 1, 2023, 2:38 a.m.)
Indexed 5 days, 15 hours ago (Aug. 29, 2025, 6:16 a.m.)
Issued 15 years, 3 months ago (May 19, 2010)
Published 15 years, 3 months ago (May 19, 2010)
Published Online 15 years, 3 months ago (May 19, 2010)
Published Print 15 years, 3 months ago (June 1, 2010)
Funders 0

None